News
Eight out of 10 Antibody Therapy Available for Treatment of #COVID19 Patients Do Not ... - Latest Tweet by IANS India
The latest Tweet by IANS India states, 'Eight out of 10 antibody therapy available for treatment of #COVID19 patients do not inhibit the new and emerging sub-variants of #Omicron such as BA.2.12.1, BA.4, and BA.5, according to a study published in The Lancet Infectious Diseases.'
Eight out of 10 antibody therapy available for treatment of #COVID19 patients do not inhibit the new and emerging sub-variants of #Omicron such as BA.2.12.1, BA.4, and BA.5, according to a study published in The Lancet Infectious Diseases. pic.twitter.com/06WdC9w0BM— IANS (@ians_india) July 3, 2022
(The above story first appeared on LatestLY on Jul 03, 2022 03:14 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
